[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Recombinant Carboxypeptidase B Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

March 2023 | 105 pages | ID: G0C2BE366F0EEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Recombinant Carboxypeptidase B market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Recombinant Carboxypeptidase B market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Purity and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Recombinant Carboxypeptidase B market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029

Global Recombinant Carboxypeptidase B market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029

Global Recombinant Carboxypeptidase B market size and forecasts, by Purity and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029

Global Recombinant Carboxypeptidase B market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Recombinant Carboxypeptidase B

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Recombinant Carboxypeptidase B market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, PeproTech, Prospec Bio, BPS Bioscience and Shanghai Yaxin Biotechnology Co., Ltd., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation

Recombinant Carboxypeptidase B market is split by Purity and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Purity, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Purity
  • ?90%
  • ?95%
  • Others
Market segment by Application
  • Functional Studies
  • SDS-PAGE
  • HPLC
  • Others
Major players covered
  • Roche
  • PeproTech
  • Prospec Bio
  • BPS Bioscience
  • Shanghai Yaxin Biotechnology Co., Ltd.
  • R&D Systems
  • RayBiotech
  • Abcam
  • Advent Bio
  • Innovative Researc
  • enQuire BioReagents
  • Lonza Bioscience
  • Boster Bio
  • ProSci
Market segment by region, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Recombinant Carboxypeptidase B product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Recombinant Carboxypeptidase B, with price, sales, revenue and global market share of Recombinant Carboxypeptidase B from 2018 to 2023.

Chapter 3, the Recombinant Carboxypeptidase B competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Recombinant Carboxypeptidase B breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.

Chapter 5 and 6, to segment the sales by Purity and application, with sales market share and growth rate by purity, application, from 2018 to 2029.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Recombinant Carboxypeptidase B market forecast, by regions, purity and application, with sales and revenue, from 2024 to 2029.

Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.

Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Carboxypeptidase B.

Chapter 14 and 15, to describe Recombinant Carboxypeptidase B sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Recombinant Carboxypeptidase B
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Purity
  1.3.1 Overview: Global Recombinant Carboxypeptidase B Consumption Value by Purity: 2018 Versus 2022 Versus 2029
  1.3.2 ?90%
  1.3.3 ?95%
  1.3.4 Others
1.4 Market Analysis by Application
  1.4.1 Overview: Global Recombinant Carboxypeptidase B Consumption Value by Application: 2018 Versus 2022 Versus 2029
  1.4.2 Functional Studies
  1.4.3 SDS-PAGE
  1.4.4 HPLC
  1.4.5 Others
1.5 Global Recombinant Carboxypeptidase B Market Size & Forecast
  1.5.1 Global Recombinant Carboxypeptidase B Consumption Value (2018 & 2022 & 2029)
  1.5.2 Global Recombinant Carboxypeptidase B Sales Quantity (2018-2029)
  1.5.3 Global Recombinant Carboxypeptidase B Average Price (2018-2029)

2 MANUFACTURERS PROFILES

2.1 Roche
  2.1.1 Roche Details
  2.1.2 Roche Major Business
  2.1.3 Roche Recombinant Carboxypeptidase B Product and Services
  2.1.4 Roche Recombinant Carboxypeptidase B Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.1.5 Roche Recent Developments/Updates
2.2 PeproTech
  2.2.1 PeproTech Details
  2.2.2 PeproTech Major Business
  2.2.3 PeproTech Recombinant Carboxypeptidase B Product and Services
  2.2.4 PeproTech Recombinant Carboxypeptidase B Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.2.5 PeproTech Recent Developments/Updates
2.3 Prospec Bio
  2.3.1 Prospec Bio Details
  2.3.2 Prospec Bio Major Business
  2.3.3 Prospec Bio Recombinant Carboxypeptidase B Product and Services
  2.3.4 Prospec Bio Recombinant Carboxypeptidase B Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.3.5 Prospec Bio Recent Developments/Updates
2.4 BPS Bioscience
  2.4.1 BPS Bioscience Details
  2.4.2 BPS Bioscience Major Business
  2.4.3 BPS Bioscience Recombinant Carboxypeptidase B Product and Services
  2.4.4 BPS Bioscience Recombinant Carboxypeptidase B Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.4.5 BPS Bioscience Recent Developments/Updates
2.5 Shanghai Yaxin Biotechnology Co., Ltd.
  2.5.1 Shanghai Yaxin Biotechnology Co., Ltd. Details
  2.5.2 Shanghai Yaxin Biotechnology Co., Ltd. Major Business
  2.5.3 Shanghai Yaxin Biotechnology Co., Ltd. Recombinant Carboxypeptidase B Product and Services
  2.5.4 Shanghai Yaxin Biotechnology Co., Ltd. Recombinant Carboxypeptidase B Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.5.5 Shanghai Yaxin Biotechnology Co., Ltd. Recent Developments/Updates
2.6 R&D Systems
  2.6.1 R&D Systems Details
  2.6.2 R&D Systems Major Business
  2.6.3 R&D Systems Recombinant Carboxypeptidase B Product and Services
  2.6.4 R&D Systems Recombinant Carboxypeptidase B Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.6.5 R&D Systems Recent Developments/Updates
2.7 RayBiotech
  2.7.1 RayBiotech Details
  2.7.2 RayBiotech Major Business
  2.7.3 RayBiotech Recombinant Carboxypeptidase B Product and Services
  2.7.4 RayBiotech Recombinant Carboxypeptidase B Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.7.5 RayBiotech Recent Developments/Updates
2.8 Abcam
  2.8.1 Abcam Details
  2.8.2 Abcam Major Business
  2.8.3 Abcam Recombinant Carboxypeptidase B Product and Services
  2.8.4 Abcam Recombinant Carboxypeptidase B Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.8.5 Abcam Recent Developments/Updates
2.9 Advent Bio
  2.9.1 Advent Bio Details
  2.9.2 Advent Bio Major Business
  2.9.3 Advent Bio Recombinant Carboxypeptidase B Product and Services
  2.9.4 Advent Bio Recombinant Carboxypeptidase B Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.9.5 Advent Bio Recent Developments/Updates
2.10 Innovative Researc
  2.10.1 Innovative Researc Details
  2.10.2 Innovative Researc Major Business
  2.10.3 Innovative Researc Recombinant Carboxypeptidase B Product and Services
  2.10.4 Innovative Researc Recombinant Carboxypeptidase B Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.10.5 Innovative Researc Recent Developments/Updates
2.11 enQuire BioReagents
  2.11.1 enQuire BioReagents Details
  2.11.2 enQuire BioReagents Major Business
  2.11.3 enQuire BioReagents Recombinant Carboxypeptidase B Product and Services
  2.11.4 enQuire BioReagents Recombinant Carboxypeptidase B Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.11.5 enQuire BioReagents Recent Developments/Updates
2.12 Lonza Bioscience
  2.12.1 Lonza Bioscience Details
  2.12.2 Lonza Bioscience Major Business
  2.12.3 Lonza Bioscience Recombinant Carboxypeptidase B Product and Services
  2.12.4 Lonza Bioscience Recombinant Carboxypeptidase B Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.12.5 Lonza Bioscience Recent Developments/Updates
2.13 Boster Bio
  2.13.1 Boster Bio Details
  2.13.2 Boster Bio Major Business
  2.13.3 Boster Bio Recombinant Carboxypeptidase B Product and Services
  2.13.4 Boster Bio Recombinant Carboxypeptidase B Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.13.5 Boster Bio Recent Developments/Updates
2.14 ProSci
  2.14.1 ProSci Details
  2.14.2 ProSci Major Business
  2.14.3 ProSci Recombinant Carboxypeptidase B Product and Services
  2.14.4 ProSci Recombinant Carboxypeptidase B Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.14.5 ProSci Recent Developments/Updates

3 COMPETITIVE ENVIRONMENT: RECOMBINANT CARBOXYPEPTIDASE B BY MANUFACTURER

3.1 Global Recombinant Carboxypeptidase B Sales Quantity by Manufacturer (2018-2023)
3.2 Global Recombinant Carboxypeptidase B Revenue by Manufacturer (2018-2023)
3.3 Global Recombinant Carboxypeptidase B Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
  3.4.1 Producer Shipments of Recombinant Carboxypeptidase B by Manufacturer Revenue ($MM) and Market Share (%): 2022
  3.4.2 Top 3 Recombinant Carboxypeptidase B Manufacturer Market Share in 2022
  3.4.2 Top 6 Recombinant Carboxypeptidase B Manufacturer Market Share in 2022
3.5 Recombinant Carboxypeptidase B Market: Overall Company Footprint Analysis
  3.5.1 Recombinant Carboxypeptidase B Market: Region Footprint
  3.5.2 Recombinant Carboxypeptidase B Market: Company Product Type Footprint
  3.5.3 Recombinant Carboxypeptidase B Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 CONSUMPTION ANALYSIS BY REGION

4.1 Global Recombinant Carboxypeptidase B Market Size by Region
  4.1.1 Global Recombinant Carboxypeptidase B Sales Quantity by Region (2018-2029)
  4.1.2 Global Recombinant Carboxypeptidase B Consumption Value by Region (2018-2029)
  4.1.3 Global Recombinant Carboxypeptidase B Average Price by Region (2018-2029)
4.2 North America Recombinant Carboxypeptidase B Consumption Value (2018-2029)
4.3 Europe Recombinant Carboxypeptidase B Consumption Value (2018-2029)
4.4 Asia-Pacific Recombinant Carboxypeptidase B Consumption Value (2018-2029)
4.5 South America Recombinant Carboxypeptidase B Consumption Value (2018-2029)
4.6 Middle East and Africa Recombinant Carboxypeptidase B Consumption Value (2018-2029)

5 MARKET SEGMENT BY PURITY

5.1 Global Recombinant Carboxypeptidase B Sales Quantity by Purity (2018-2029)
5.2 Global Recombinant Carboxypeptidase B Consumption Value by Purity (2018-2029)
5.3 Global Recombinant Carboxypeptidase B Average Price by Purity (2018-2029)

6 MARKET SEGMENT BY APPLICATION

6.1 Global Recombinant Carboxypeptidase B Sales Quantity by Application (2018-2029)
6.2 Global Recombinant Carboxypeptidase B Consumption Value by Application (2018-2029)
6.3 Global Recombinant Carboxypeptidase B Average Price by Application (2018-2029)

7 NORTH AMERICA

7.1 North America Recombinant Carboxypeptidase B Sales Quantity by Purity (2018-2029)
7.2 North America Recombinant Carboxypeptidase B Sales Quantity by Application (2018-2029)
7.3 North America Recombinant Carboxypeptidase B Market Size by Country
  7.3.1 North America Recombinant Carboxypeptidase B Sales Quantity by Country (2018-2029)
  7.3.2 North America Recombinant Carboxypeptidase B Consumption Value by Country (2018-2029)
  7.3.3 United States Market Size and Forecast (2018-2029)
  7.3.4 Canada Market Size and Forecast (2018-2029)
  7.3.5 Mexico Market Size and Forecast (2018-2029)

8 EUROPE

8.1 Europe Recombinant Carboxypeptidase B Sales Quantity by Purity (2018-2029)
8.2 Europe Recombinant Carboxypeptidase B Sales Quantity by Application (2018-2029)
8.3 Europe Recombinant Carboxypeptidase B Market Size by Country
  8.3.1 Europe Recombinant Carboxypeptidase B Sales Quantity by Country (2018-2029)
  8.3.2 Europe Recombinant Carboxypeptidase B Consumption Value by Country (2018-2029)
  8.3.3 Germany Market Size and Forecast (2018-2029)
  8.3.4 France Market Size and Forecast (2018-2029)
  8.3.5 United Kingdom Market Size and Forecast (2018-2029)
  8.3.6 Russia Market Size and Forecast (2018-2029)
  8.3.7 Italy Market Size and Forecast (2018-2029)

9 ASIA-PACIFIC

9.1 Asia-Pacific Recombinant Carboxypeptidase B Sales Quantity by Purity (2018-2029)
9.2 Asia-Pacific Recombinant Carboxypeptidase B Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Recombinant Carboxypeptidase B Market Size by Region
  9.3.1 Asia-Pacific Recombinant Carboxypeptidase B Sales Quantity by Region (2018-2029)
  9.3.2 Asia-Pacific Recombinant Carboxypeptidase B Consumption Value by Region (2018-2029)
  9.3.3 China Market Size and Forecast (2018-2029)
  9.3.4 Japan Market Size and Forecast (2018-2029)
  9.3.5 Korea Market Size and Forecast (2018-2029)
  9.3.6 India Market Size and Forecast (2018-2029)
  9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
  9.3.8 Australia Market Size and Forecast (2018-2029)

10 SOUTH AMERICA

10.1 South America Recombinant Carboxypeptidase B Sales Quantity by Purity (2018-2029)
10.2 South America Recombinant Carboxypeptidase B Sales Quantity by Application (2018-2029)
10.3 South America Recombinant Carboxypeptidase B Market Size by Country
  10.3.1 South America Recombinant Carboxypeptidase B Sales Quantity by Country (2018-2029)
  10.3.2 South America Recombinant Carboxypeptidase B Consumption Value by Country (2018-2029)
  10.3.3 Brazil Market Size and Forecast (2018-2029)
  10.3.4 Argentina Market Size and Forecast (2018-2029)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Recombinant Carboxypeptidase B Sales Quantity by Purity (2018-2029)
11.2 Middle East & Africa Recombinant Carboxypeptidase B Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Recombinant Carboxypeptidase B Market Size by Country
  11.3.1 Middle East & Africa Recombinant Carboxypeptidase B Sales Quantity by Country (2018-2029)
  11.3.2 Middle East & Africa Recombinant Carboxypeptidase B Consumption Value by Country (2018-2029)
  11.3.3 Turkey Market Size and Forecast (2018-2029)
  11.3.4 Egypt Market Size and Forecast (2018-2029)
  11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
  11.3.6 South Africa Market Size and Forecast (2018-2029)

12 MARKET DYNAMICS

12.1 Recombinant Carboxypeptidase B Market Drivers
12.2 Recombinant Carboxypeptidase B Market Restraints
12.3 Recombinant Carboxypeptidase B Trends Analysis
12.4 Porters Five Forces Analysis
  12.4.1 Threat of New Entrants
  12.4.2 Bargaining Power of Suppliers
  12.4.3 Bargaining Power of Buyers
  12.4.4 Threat of Substitutes
  12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
  12.5.1 Influence of COVID-19
  12.5.2 Influence of Russia-Ukraine War

13 RAW MATERIAL AND INDUSTRY CHAIN

13.1 Raw Material of Recombinant Carboxypeptidase B and Key Manufacturers
13.2 Manufacturing Costs Percentage of Recombinant Carboxypeptidase B
13.3 Recombinant Carboxypeptidase B Production Process
13.4 Recombinant Carboxypeptidase B Industrial Chain

14 SHIPMENTS BY DISTRIBUTION CHANNEL

14.1 Sales Channel
  14.1.1 Direct to End-User
  14.1.2 Distributors
14.2 Recombinant Carboxypeptidase B Typical Distributors
14.3 Recombinant Carboxypeptidase B Typical Customers

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

LIST OF TABLES

Table 1. Global Recombinant Carboxypeptidase B Consumption Value by Purity, (USD Million), 2018 & 2022 & 2029
Table 2. Global Recombinant Carboxypeptidase B Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Recombinant Carboxypeptidase B Product and Services
Table 6. Roche Recombinant Carboxypeptidase B Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Roche Recent Developments/Updates
Table 8. PeproTech Basic Information, Manufacturing Base and Competitors
Table 9. PeproTech Major Business
Table 10. PeproTech Recombinant Carboxypeptidase B Product and Services
Table 11. PeproTech Recombinant Carboxypeptidase B Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. PeproTech Recent Developments/Updates
Table 13. Prospec Bio Basic Information, Manufacturing Base and Competitors
Table 14. Prospec Bio Major Business
Table 15. Prospec Bio Recombinant Carboxypeptidase B Product and Services
Table 16. Prospec Bio Recombinant Carboxypeptidase B Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Prospec Bio Recent Developments/Updates
Table 18. BPS Bioscience Basic Information, Manufacturing Base and Competitors
Table 19. BPS Bioscience Major Business
Table 20. BPS Bioscience Recombinant Carboxypeptidase B Product and Services
Table 21. BPS Bioscience Recombinant Carboxypeptidase B Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. BPS Bioscience Recent Developments/Updates
Table 23. Shanghai Yaxin Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Shanghai Yaxin Biotechnology Co., Ltd. Major Business
Table 25. Shanghai Yaxin Biotechnology Co., Ltd. Recombinant Carboxypeptidase B Product and Services
Table 26. Shanghai Yaxin Biotechnology Co., Ltd. Recombinant Carboxypeptidase B Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Shanghai Yaxin Biotechnology Co., Ltd. Recent Developments/Updates
Table 28. R&D Systems Basic Information, Manufacturing Base and Competitors
Table 29. R&D Systems Major Business
Table 30. R&D Systems Recombinant Carboxypeptidase B Product and Services
Table 31. R&D Systems Recombinant Carboxypeptidase B Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. R&D Systems Recent Developments/Updates
Table 33. RayBiotech Basic Information, Manufacturing Base and Competitors
Table 34. RayBiotech Major Business
Table 35. RayBiotech Recombinant Carboxypeptidase B Product and Services
Table 36. RayBiotech Recombinant Carboxypeptidase B Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. RayBiotech Recent Developments/Updates
Table 38. Abcam Basic Information, Manufacturing Base and Competitors
Table 39. Abcam Major Business
Table 40. Abcam Recombinant Carboxypeptidase B Product and Services
Table 41. Abcam Recombinant Carboxypeptidase B Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Abcam Recent Developments/Updates
Table 43. Advent Bio Basic Information, Manufacturing Base and Competitors
Table 44. Advent Bio Major Business
Table 45. Advent Bio Recombinant Carboxypeptidase B Product and Services
Table 46. Advent Bio Recombinant Carboxypeptidase B Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Advent Bio Recent Developments/Updates
Table 48. Innovative Researc Basic Information, Manufacturing Base and Competitors
Table 49. Innovative Researc Major Business
Table 50. Innovative Researc Recombinant Carboxypeptidase B Product and Services
Table 51. Innovative Researc Recombinant Carboxypeptidase B Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Innovative Researc Recent Developments/Updates
Table 53. enQuire BioReagents Basic Information, Manufacturing Base and Competitors
Table 54. enQuire BioReagents Major Business
Table 55. enQuire BioReagents Recombinant Carboxypeptidase B Product and Services
Table 56. enQuire BioReagents Recombinant Carboxypeptidase B Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. enQuire BioReagents Recent Developments/Updates
Table 58. Lonza Bioscience Basic Information, Manufacturing Base and Competitors
Table 59. Lonza Bioscience Major Business
Table 60. Lonza Bioscience Recombinant Carboxypeptidase B Product and Services
Table 61. Lonza Bioscience Recombinant Carboxypeptidase B Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Lonza Bioscience Recent Developments/Updates
Table 63. Boster Bio Basic Information, Manufacturing Base and Competitors
Table 64. Boster Bio Major Business
Table 65. Boster Bio Recombinant Carboxypeptidase B Product and Services
Table 66. Boster Bio Recombinant Carboxypeptidase B Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Boster Bio Recent Developments/Updates
Table 68. ProSci Basic Information, Manufacturing Base and Competitors
Table 69. ProSci Major Business
Table 70. ProSci Recombinant Carboxypeptidase B Product and Services
Table 71. ProSci Recombinant Carboxypeptidase B Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. ProSci Recent Developments/Updates
Table 73. Global Recombinant Carboxypeptidase B Sales Quantity by Manufacturer (2018-2023) & (Tons)
Table 74. Global Recombinant Carboxypeptidase B Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Recombinant Carboxypeptidase B Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 76. Market Position of Manufacturers in Recombinant Carboxypeptidase B, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Recombinant Carboxypeptidase B Production Site of Key Manufacturer
Table 78. Recombinant Carboxypeptidase B Market: Company Product Type Footprint
Table 79. Recombinant Carboxypeptidase B Market: Company Product Application Footprint
Table 80. Recombinant Carboxypeptidase B New Market Entrants and Barriers to Market Entry
Table 81. Recombinant Carboxypeptidase B Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Recombinant Carboxypeptidase B Sales Quantity by Region (2018-2023) & (Tons)
Table 83. Global Recombinant Carboxypeptidase B Sales Quantity by Region (2024-2029) & (Tons)
Table 84. Global Recombinant Carboxypeptidase B Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Recombinant Carboxypeptidase B Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Recombinant Carboxypeptidase B Average Price by Region (2018-2023) & (US$/Ton)
Table 87. Global Recombinant Carboxypeptidase B Average Price by Region (2024-2029) & (US$/Ton)
Table 88. Global Recombinant Carboxypeptidase B Sales Quantity by Purity (2018-2023) & (Tons)
Table 89. Global Recombinant Carboxypeptidase B Sales Quantity by Purity (2024-2029) & (Tons)
Table 90. Global Recombinant Carboxypeptidase B Consumption Value by Purity (2018-2023) & (USD Million)
Table 91. Global Recombinant Carboxypeptidase B Consumption Value by Purity (2024-2029) & (USD Million)
Table 92. Global Recombinant Carboxypeptidase B Average Price by Purity (2018-2023) & (US$/Ton)
Table 93. Global Recombinant Carboxypeptidase B Average Price by Purity (2024-2029) & (US$/Ton)
Table 94. Global Recombinant Carboxypeptidase B Sales Quantity by Application (2018-2023) & (Tons)
Table 95. Global Recombinant Carboxypeptidase B Sales Quantity by Application (2024-2029) & (Tons)
Table 96. Global Recombinant Carboxypeptidase B Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Recombinant Carboxypeptidase B Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Recombinant Carboxypeptidase B Average Price by Application (2018-2023) & (US$/Ton)
Table 99. Global Recombinant Carboxypeptidase B Average Price by Application (2024-2029) & (US$/Ton)
Table 100. North America Recombinant Carboxypeptidase B Sales Quantity by Purity (2018-2023) & (Tons)
Table 101. North America Recombinant Carboxypeptidase B Sales Quantity by Purity (2024-2029) & (Tons)
Table 102. North America Recombinant Carboxypeptidase B Sales Quantity by Application (2018-2023) & (Tons)
Table 103. North America Recombinant Carboxypeptidase B Sales Quantity by Application (2024-2029) & (Tons)
Table 104. North America Recombinant Carboxypeptidase B Sales Quantity by Country (2018-2023) & (Tons)
Table 105. North America Recombinant Carboxypeptidase B Sales Quantity by Country (2024-2029) & (Tons)
Table 106. North America Recombinant Carboxypeptidase B Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Recombinant Carboxypeptidase B Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Recombinant Carboxypeptidase B Sales Quantity by Purity (2018-2023) & (Tons)
Table 109. Europe Recombinant Carboxypeptidase B Sales Quantity by Purity (2024-2029) & (Tons)
Table 110. Europe Recombinant Carboxypeptidase B Sales Quantity by Application (2018-2023) & (Tons)
Table 111. Europe Recombinant Carboxypeptidase B Sales Quantity by Application (2024-2029) & (Tons)
Table 112. Europe Recombinant Carboxypeptidase B Sales Quantity by Country (2018-2023) & (Tons)
Table 113. Europe Recombinant Carboxypeptidase B Sales Quantity by Country (2024-2029) & (Tons)
Table 114. Europe Recombinant Carboxypeptidase B Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Recombinant Carboxypeptidase B Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Recombinant Carboxypeptidase B Sales Quantity by Purity (2018-2023) & (Tons)
Table 117. Asia-Pacific Recombinant Carboxypeptidase B Sales Quantity by Purity (2024-2029) & (Tons)
Table 118. Asia-Pacific Recombinant Carboxypeptidase B Sales Quantity by Application (2018-2023) & (Tons)
Table 119. Asia-Pacific Recombinant Carboxypeptidase B Sales Quantity by Application (2024-2029) & (Tons)
Table 120. Asia-Pacific Recombinant Carboxypeptidase B Sales Quantity by Region (2018-2023) & (Tons)
Table 121. Asia-Pacific Recombinant Carboxypeptidase B Sales Quantity by Region (2024-2029) & (Tons)
Table 122. Asia-Pacific Recombinant Carboxypeptidase B Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Recombinant Carboxypeptidase B Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Recombinant Carboxypeptidase B Sales Quantity by Purity (2018-2023) & (Tons)
Table 125. South America Recombinant Carboxypeptidase B Sales Quantity by Purity (2024-2029) & (Tons)
Table 126. South America Recombinant Carboxypeptidase B Sales Quantity by Application (2018-2023) & (Tons)
Table 127. South America Recombinant Carboxypeptidase B Sales Quantity by Application (2024-2029) & (Tons)
Table 128. South America Recombinant Carboxypeptidase B Sales Quantity by Country (2018-2023) & (Tons)
Table 129. South America Recombinant Carboxypeptidase B Sales Quantity by Country (2024-2029) & (Tons)
Table 130. South America Recombinant Carboxypeptidase B Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Recombinant Carboxypeptidase B Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Recombinant Carboxypeptidase B Sales Quantity by Purity (2018-2023) & (Tons)
Table 133. Middle East & Africa Recombinant Carboxypeptidase B Sales Quantity by Purity (2024-2029) & (Tons)
Table 134. Middle East & Africa Recombinant Carboxypeptidase B Sales Quantity by Application (2018-2023) & (Tons)
Table 135. Middle East & Africa Recombinant Carboxypeptidase B Sales Quantity by Application (2024-2029) & (Tons)
Table 136. Middle East & Africa Recombinant Carboxypeptidase B Sales Quantity by Region (2018-2023) & (Tons)
Table 137. Middle East & Africa Recombinant Carboxypeptidase B Sales Quantity by Region (2024-2029) & (Tons)
Table 138. Middle East & Africa Recombinant Carboxypeptidase B Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Recombinant Carboxypeptidase B Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Recombinant Carboxypeptidase B Raw Material
Table 141. Key Manufacturers of Recombinant Carboxypeptidase B Raw Materials
Table 142. Recombinant Carboxypeptidase B Typical Distributors
Table 143. Recombinant Carboxypeptidase B Typical Customers

LIST OF FIGURES

Figure 1. Recombinant Carboxypeptidase B Picture
Figure 2. Global Recombinant Carboxypeptidase B Consumption Value by Purity, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Recombinant Carboxypeptidase B Consumption Value Market Share by Purity in 2022
Figure 4. ?90% Examples
Figure 5. ?95% Examples
Figure 6. Others Examples
Figure 7. Global Recombinant Carboxypeptidase B Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Recombinant Carboxypeptidase B Consumption Value Market Share by Application in 2022
Figure 9. Functional Studies Examples
Figure 10. SDS-PAGE Examples
Figure 11. HPLC Examples
Figure 12. Others Examples
Figure 13. Global Recombinant Carboxypeptidase B Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Recombinant Carboxypeptidase B Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Recombinant Carboxypeptidase B Sales Quantity (2018-2029) & (Tons)
Figure 16. Global Recombinant Carboxypeptidase B Average Price (2018-2029) & (US$/Ton)
Figure 17. Global Recombinant Carboxypeptidase B Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Recombinant Carboxypeptidase B Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Recombinant Carboxypeptidase B by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Recombinant Carboxypeptidase B Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Recombinant Carboxypeptidase B Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Recombinant Carboxypeptidase B Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Recombinant Carboxypeptidase B Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Recombinant Carboxypeptidase B Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Recombinant Carboxypeptidase B Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Recombinant Carboxypeptidase B Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Recombinant Carboxypeptidase B Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Recombinant Carboxypeptidase B Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Recombinant Carboxypeptidase B Sales Quantity Market Share by Purity (2018-2029)
Figure 30. Global Recombinant Carboxypeptidase B Consumption Value Market Share by Purity (2018-2029)
Figure 31. Global Recombinant Carboxypeptidase B Average Price by Purity (2018-2029) & (US$/Ton)
Figure 32. Global Recombinant Carboxypeptidase B Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Recombinant Carboxypeptidase B Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Recombinant Carboxypeptidase B Average Price by Application (2018-2029) & (US$/Ton)
Figure 35. North America Recombinant Carboxypeptidase B Sales Quantity Market Share by Purity (2018-2029)
Figure 36. North America Recombinant Carboxypeptidase B Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Recombinant Carboxypeptidase B Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Recombinant Carboxypeptidase B Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Recombinant Carboxypeptidase B Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Recombinant Carboxypeptidase B Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Recombinant Carboxypeptidase B Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Recombinant Carboxypeptidase B Sales Quantity Market Share by Purity (2018-2029)
Figure 43. Europe Recombinant Carboxypeptidase B Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Recombinant Carboxypeptidase B Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Recombinant Carboxypeptidase B Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Recombinant Carboxypeptidase B Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Recombinant Carboxypeptidase B Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Recombinant Carboxypeptidase B Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Recombinant Carboxypeptidase B Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Recombinant Carboxypeptidase B Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Recombinant Carboxypeptidase B Sales Quantity Market Share by Purity (2018-2029)
Figure 52. Asia-Pacific Recombinant Carboxypeptidase B Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Recombinant Carboxypeptidase B Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Recombinant Carboxypeptidase B Consumption Value Market Share by Region (2018-2029)
Figure 55. China Recombinant Carboxypeptidase B Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Recombinant Carboxypeptidase B Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Recombinant Carboxypeptidase B Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Recombinant Carboxypeptidase B Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Recombinant Carboxypeptidase B Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Recombinant Carboxypeptidase B Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Recombinant Carboxypeptidase B Sales Quantity Market Share by Purity (2018-2029)
Figure 62. South America Recombinant Carboxypeptidase B Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Recombinant Carboxypeptidase B Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Recombinant Carboxypeptidase B Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Recombinant Carboxypeptidase B Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Recombinant Carboxypeptidase B Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Recombinant Carboxypeptidase B Sales Quantity Market Share by Purity (2018-2029)
Figure 68. Middle East & Africa Recombinant Carboxypeptidase B Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Recombinant Carboxypeptidase B Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Recombinant Carboxypeptidase B Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Recombinant Carboxypeptidase B Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Recombinant Carboxypeptidase B Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Recombinant Carboxypeptidase B Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Recombinant Carboxypeptidase B Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Recombinant Carboxypeptidase B Market Drivers
Figure 76. Recombinant Carboxypeptidase B Market Restraints
Figure 77. Recombinant Carboxypeptidase B Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Recombinant Carboxypeptidase B in 2022
Figure 80. Manufacturing Process Analysis of Recombinant Carboxypeptidase B
Figure 81. Recombinant Carboxypeptidase B Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source


More Publications